296 related articles for article (PubMed ID: 27587228)
1. Early responses assessment of neoadjuvant chemotherapy in nasopharyngeal carcinoma by serial dynamic contrast-enhanced MR imaging.
Zheng D; Yue Q; Ren W; Liu M; Zhang X; Lin H; Lai G; Chen W; Chan Q; Chen Y
Magn Reson Imaging; 2017 Jan; 35():125-131. PubMed ID: 27587228
[TBL] [Abstract][Full Text] [Related]
2. Early response to chemoradiotherapy for nasopharyngeal carcinoma treatment: Value of dynamic contrast-enhanced 3.0 T MRI.
Zheng D; Chen Y; Liu X; Chen Y; Xu L; Ren W; Chen W; Chan Q
J Magn Reson Imaging; 2015 Jun; 41(6):1528-40. PubMed ID: 25136770
[TBL] [Abstract][Full Text] [Related]
3. Integrating dynamic contrast-enhanced magnetic resonance imaging and diffusion kurtosis imaging for neoadjuvant chemotherapy assessment of nasopharyngeal carcinoma.
Zheng D; Lai G; Chen Y; Yue Q; Liu X; Chen X; Chen W; Chan Q; Chen Y
J Magn Reson Imaging; 2018 Nov; 48(5):1208-1216. PubMed ID: 29693765
[TBL] [Abstract][Full Text] [Related]
4. Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) for pretreatment prediction of neoadjuvant chemotherapy response in locally advanced hypopharyngeal cancer.
Guo W; Zhang Y; Luo D; Yuan H
Br J Radiol; 2020 Nov; 93(1115):20200751. PubMed ID: 32915647
[No Abstract] [Full Text] [Related]
5. Diffusion-weighted magnetic resonance imaging for early response assessment of chemoradiotherapy in patients with nasopharyngeal carcinoma.
Chen Y; Liu X; Zheng D; Xu L; Hong L; Xu Y; Pan J
Magn Reson Imaging; 2014 Jul; 32(6):630-7. PubMed ID: 24703576
[TBL] [Abstract][Full Text] [Related]
6. The Usefulness of Pretreatment MR-Based Radiomics on Early Response of Neoadjuvant Chemotherapy in Patients With Locally Advanced Nasopharyngeal Carcinoma.
Yongfeng P; Chuner J; Lei W; Fengqin Y; Zhimin Y; Zhenfu F; Haitao J; Yangming J; Fangzheng W
Oncol Res; 2021 Mar; 28(6):605-613. PubMed ID: 33523792
[TBL] [Abstract][Full Text] [Related]
7. Dynamic contrast-enhanced MRI of nasopharyngeal carcinoma: a preliminary study of the correlations between quantitative parameters and clinical stage.
Zheng D; Chen Y; Chen Y; Xu L; Chen W; Yao Y; Du Z; Deng X; Chan Q
J Magn Reson Imaging; 2014 Apr; 39(4):940-8. PubMed ID: 24108569
[TBL] [Abstract][Full Text] [Related]
8. Intravoxel Incoherent Motion-Magnetic Resonance Imaging as an Early Predictor of Treatment Response to Neoadjuvant Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma.
Xiao Y; Pan J; Chen Y; Chen Y; He Z; Zheng X
Medicine (Baltimore); 2015 Jun; 94(24):e973. PubMed ID: 26091468
[TBL] [Abstract][Full Text] [Related]
9. Pretreatment MR imaging radiomics signatures for response prediction to induction chemotherapy in patients with nasopharyngeal carcinoma.
Wang G; He L; Yuan C; Huang Y; Liu Z; Liang C
Eur J Radiol; 2018 Jan; 98():100-106. PubMed ID: 29279146
[TBL] [Abstract][Full Text] [Related]
10. Multiparametric magnetic resonance imaging for predicting pathological response after the first cycle of neoadjuvant chemotherapy in breast cancer.
Li X; Abramson RG; Arlinghaus LR; Kang H; Chakravarthy AB; Abramson VG; Farley J; Mayer IA; Kelley MC; Meszoely IM; Means-Powell J; Grau AM; Sanders M; Yankeelov TE
Invest Radiol; 2015 Apr; 50(4):195-204. PubMed ID: 25360603
[TBL] [Abstract][Full Text] [Related]
11. Diffusion kurtosis imaging predicts neoadjuvant chemotherapy responses within 4 days in advanced nasopharyngeal carcinoma patients.
Chen Y; Ren W; Zheng D; Zhong J; Liu X; Yue Q; Liu M; Xiao Y; Chen W; Chan Q; Pan J
J Magn Reson Imaging; 2015 Nov; 42(5):1354-61. PubMed ID: 25873208
[TBL] [Abstract][Full Text] [Related]
12. Early assessment of response to chemotherapy in lung cancer using dynamic contrast-enhanced MRI: a proof-of-concept study.
Xu J; Mei L; Liu L; Wang K; Zhou Z; Zheng J
Clin Radiol; 2018 Jul; 73(7):625-631. PubMed ID: 29571650
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the pre-treatment functional MRI metrics' efficacy in predicting Locoregionally advanced nasopharyngeal carcinoma response to induction chemotherapy.
Zhao DW; Fan WJ; Meng LL; Luo YR; Wei J; Liu K; Liu G; Li JF; Zang X; Li M; Zhang XX; Ma L
Cancer Imaging; 2021 Nov; 21(1):59. PubMed ID: 34758876
[TBL] [Abstract][Full Text] [Related]
14. Dynamic contrast-enhanced and diffusion-weighted MR imaging in early prediction of pathologic response to neoadjuvant chemotherapy in locally advanced gastric cancer.
Li J; Yan LL; Zhang HK; Wang Y; Xu SN; Li HL; Qu JR
Abdom Radiol (NY); 2022 Oct; 47(10):3394-3405. PubMed ID: 35916943
[TBL] [Abstract][Full Text] [Related]
15. Early Prediction of Response to Neoadjuvant Chemotherapy Using Dynamic Contrast-Enhanced MRI and Ultrasound in Breast Cancer.
Kim Y; Kim SH; Song BJ; Kang BJ; Yim KI; Lee A; Nam Y
Korean J Radiol; 2018; 19(4):682-691. PubMed ID: 29962874
[TBL] [Abstract][Full Text] [Related]
16. Use of texture analysis based on contrast-enhanced MRI to predict treatment response to chemoradiotherapy in nasopharyngeal carcinoma.
Liu J; Mao Y; Li Z; Zhang D; Zhang Z; Hao S; Li B
J Magn Reson Imaging; 2016 Aug; 44(2):445-55. PubMed ID: 26778191
[TBL] [Abstract][Full Text] [Related]
17. Breast cancer: early prediction of response to neoadjuvant chemotherapy using parametric response maps for MR imaging.
Cho N; Im SA; Park IA; Lee KH; Li M; Han W; Noh DY; Moon WK
Radiology; 2014 Aug; 272(2):385-96. PubMed ID: 24738612
[TBL] [Abstract][Full Text] [Related]
18. Quantitative evaluation of breast cancer response to neoadjuvant chemotherapy by diffusion tensor imaging: Initial results.
Furman-Haran E; Nissan N; Ricart-Selma V; Martinez-Rubio C; Degani H; Camps-Herrero J
J Magn Reson Imaging; 2018 Apr; 47(4):1080-1090. PubMed ID: 28901594
[TBL] [Abstract][Full Text] [Related]
19. Early evaluation of irradiated parotid glands with intravoxel incoherent motion MR imaging: correlation with dynamic contrast-enhanced MR imaging.
Zhou N; Chu C; Dou X; Li M; Liu S; Zhu L; Liu B; Guo T; Chen W; He J; Yan J; Zhou Z; Yang X; Liu T
BMC Cancer; 2016 Nov; 16(1):865. PubMed ID: 27821130
[TBL] [Abstract][Full Text] [Related]
20. Quantitative Analysis of DCE-MRI and RESOLVE-DWI for Differentiating Nasopharyngeal Carcinoma from Nasopharyngeal Lymphoid Hyperplasia.
Yu JY; Zhang D; Huang XL; Ma J; Yang C; Li XJ; Xiong H; Zhou B; Liao RK; Tang ZY
J Med Syst; 2020 Feb; 44(4):75. PubMed ID: 32103352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
